Chapter 1. CANCER TESTING/SCREENING MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. CANCER TESTING/SCREENING MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-121 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. CANCER TESTING/SCREENING MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. CANCER TESTING/SCREENING MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. CANCER TESTING/SCREENING MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. CANCER TESTING/SCREENING MARKET– By Type

6.1. Diagnostics

6.2. Screening

Chapter 7. CANCER TESTING/SCREENING MARKET– By Cancer Type

7.1. Respiratory System Cancer

7.2. Leukemia

7.3. Myeloma and Lymphoma

7.4. Skin Cancer

7.5. Abdominal/Digestive System Cancer

7.6. Genital Cancer

7.7. Oral Cancer

7.8. Urinary System Cancer

7.9.  Endocrine System Cancer

7.11. Breast Cancer

7.12.  Others

Chapter 8. CANCER TESTING/SCREENING MARKET– By Technique

8.1. Imaging

8.2. Biopsy

8.3. Genomic and Molecular Tests

8.4. Others

Chapter 9. CANCER TESTING/SCREENING MARKET– By Product Type

9.1. Molecular Diagnostics

9.2. Companion Diagnostics

Chapter 10. CANCER TESTING/SCREENING MARKET– By Stage

10.1. Terminal

10.2. Stage 0-4

10.3. Prognosis

10.4. Other Staging System

Chapter 11. CANCER TESTING/SCREENING MARKET– By Region

11.1. North America

11.2. Europe

11.3. The Asia Pacific

11.4. Latin America

11.5. Middle-East and Africa

Chapter 12. CANCER TESTING/SCREENING MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

12.1. Company 1

12.2. Company 2

12.3. Company 3

12.4. Company 4

12.5. Company 5

12.6. Company 6

12.7. Company 7

12.8. Company 8

12.9. Company 9

12.10. Company 10